Evidence-based digital medicine for stigmatized illnesses
Prognoix's investors include NUS Enterprise, YES!Delft, Abhinav Jain, Christoph Pies, Shriekanth Iyer.
Prognoix is headquartered in Singapore, Singapore.
Evidence-based digital medicine for stigmatized illnesses
Prognoix is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prognoix — Funding & Investors." VCBacked, February 1, 2023, https://www.vcbacked.co/company/prognoix. Accessed August 14, 2026.
VCBacked. (2023). Prognoix — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/prognoix
{{cite web |title=Prognoix — Funding & Investors |url=https://www.vcbacked.co/company/prognoix |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated